声音生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按技术、适应症、最终用户、地区和竞争进行细分，2020-2030 年预测

2024 年全球声音生物标记市场价值为 20.1 亿美元，预计在预测期内将实现强劲增长，到 2030 年的复合年增长率为 9.32%。全球声音生物标记市场是医疗保健和技术产业中一个迅速崛起且充满活力的领域，由语音分析和人工智慧的创新整合所推动。声音生物标记是一个革命性的概念，它利用我们声音中蕴含的丰富资讯来诊断、监测和预测各种医疗状况。由于其非侵入性以及透过提供早期检测和个人化治疗解决方案来改变医疗保健的潜力，该市场正在获得巨大的发展动力。例如，根据美国国家医学图书馆发表的一篇题为“声音作为健康技术中的生物标誌物：绘製初创企业世界中声音生物标誌物不断发展的格局”的文章，使用声音作为生物标誌物在健康技术中越来越受欢迎。该研究强调了新创公司在利用基于语音的分析进行健康监测、诊断和疾病管理方面发挥着越来越大的作用，强调了声音生物标记在数位健康领域的变革潜力。

主要市场驱动因素

慢性病盛行率上升

主要市场挑战

隐私和资料安全问题

主要市场趋势

远距医疗和远距病人监控

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球声音生物标记市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依技术（频率、振幅、错误率、声音上升或下降时间、发声时间、声音震颤、音调、其他）
  • 依适应症（精神疾病、呼吸系统疾病、心血管疾病、创伤性脑损伤 (TBI)、神经系统疾病、其他）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 依技术分类
  • 按适应症
  • 按最终用户
  • 按地区

第五章：亚太地区声音生物标记市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依技术
  • 按适应症
  • 按最终用户
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲声音生物标誌物市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美声音生物标誌物市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲声音生物标誌物市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲声音生物标记市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 埃及

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 12 章：全球声音生物标记市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• IBM Corporation
• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING

第 15 章：策略建议

第16章调查会社について・免责事项

Global Vocal Biomarker Market was valued at USD 2.01 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.32% through 2030. The Global Vocal Biomarker Market is a rapidly emerging and dynamic sector within the healthcare and technology industries, driven by the innovative integration of voice analysis and artificial intelligence. Vocal biomarkers are a revolutionary concept that leverages the wealth of information embedded in our voices to diagnose, monitor, and predict various medical conditions. This market is gaining substantial traction due to its non-invasive nature and the potential to transform healthcare by providing early detection and personalized treatment solutions. For instance, according to an article published in the National Library of Medicine titled "Voice as a Biomarker in Health-Tech: Mapping the Evolving Landscape of Voice Biomarkers in the Start-Up World," the use of voice as a biomarker is gaining traction in health technology. The study highlights the growing role of startups in leveraging voice-based analytics for health monitoring, diagnosis, and disease management, emphasizing the transformative potential of vocal biomarkers in the digital health landscape.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant driving force behind the burgeoning Global Vocal Biomarker Market. Chronic diseases, such as diabetes, cardiovascular conditions, respiratory disorders, and mental health issues, have reached epidemic proportions worldwide. These conditions often require continuous monitoring, early detection, and personalized interventions to manage effectively. Vocal biomarkers, which harness the power of voice analysis and artificial intelligence, have emerged as a non-invasive and cost-effective solution to address the challenges posed by these chronic health issues. For instance, non-communicable diseases (NCDs), including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, are long-lasting and non-transmissible, posing a growing global health challenge. In 2019, NCDs caused 12 million deaths in the Western Pacific Region. Despite earlier progress in reducing premature deaths, new risk factors and changing environments have reversed gains in some countries over the past decade. Additionally, in 2021, neurological conditions accounted for 443 million disability-adjusted life years (DALYs) lost to illness, disability, and premature death, surpassing cardiovascular diseases as the leading contributor to the global disease burden.

Vocal biomarkers offer a unique advantage in the management of chronic diseases by enabling the detection of subtle changes in a person's voice over time. For instance, in diabetes management, vocal biomarkers can aid in the remote monitoring of glucose levels and associated fluctuations. This innovative approach provides an unobtrusive way for individuals to track their health status, reducing the need for frequent clinic visits and empowering patients to take charge of their well-being.

Key Market Challenges

Privacy and Data Security Concerns

The Global Vocal Biomarker Market holds great promise in the field of healthcare, offering innovative solutions for the diagnosis and monitoring of various medical conditions through the analysis of voice data. However, its growth is significantly hindered by pressing privacy and data security concerns that cast a shadow over the adoption of this technology.

One of the foremost challenges that vocal biomarkers face is the handling and safeguarding of sensitive voice data. Voice recordings carry highly personal and identifiable information, making them a potential goldmine for malicious actors if not adequately protected. Patients and healthcare providers alike are rightfully concerned about the potential misuse or unauthorized access to such data.

Implementing robust encryption measures is fundamental to ensuring the security of voice data. Utilizing end-to-end encryption and other state-of-the-art data protection techniques can safeguard voice recordings throughout their collection, transmission, and storage.

Patients should have control over their voice data, and informed consent should be obtained before recording and analyzing their voices. Users must be aware of how their data will be used and have the ability to revoke access at any time.

Key Market Trends

Telemedicine and Remote Patient Monitoring

Telemedicine and remote patient monitoring are emerging as powerful drivers behind the surge of the Global Vocal Biomarker Market. These healthcare trends, accelerated by the COVID-19 pandemic, are reshaping the way medical services are delivered and are creating a favorable environment for the adoption of vocal biomarkers.

Telemedicine, which involves providing medical consultations and healthcare services remotely, has gained immense popularity due to its convenience and the imperative to maintain social distancing during the pandemic. Patients now have the option to record their voices using smartphones or specialized devices and share this data with healthcare providers for analysis. Vocal biomarkers, through their non-invasive nature, enable patients to actively participate in their own healthcare, allowing for the remote monitoring of various medical conditions, from mental health assessments to the diagnosis and monitoring of chronic diseases.

Key Market Players

• IBM Corporation
• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING

Report Scope:

In this report, the Global Vocal Biomarker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vocal Biomarker Market, By Technique:

• Frequency
• Amplitude
• Error Rate
• Vocal Rise or Fall Time
• Phonation Time
• Vocal Tremor
• Pitch
• Others

Vocal Biomarker Market, By Indication:

• Psychiatric Disorders
• Respiratory Disorders
• Cardiovascular Disorders
• Traumatic Brain Injury (TBI)
• Neurological disorders
• Other

Vocal Biomarker Market, By End User:

• Hospitals & clinics
• Ambulatory Surgical Services
• Others

Vocal Biomarker Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vocal Biomarker Market.

Available Customizations:

Global Vocal Biomarker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Vocal Biomarker Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technique (Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, Others)
  • 4.2.2. By Indication (Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Neurological disorders, Other)
  • 4.2.3. By End-User (Hospitals & Clinics, Ambulatory care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Technique
  • 4.3.2. By Indication
  • 4.3.3. By End-User
  • 4.3.4. By Region

5. Asia Pacific Vocal Biomarker Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique
  • 5.2.2. By Indication
  • 5.2.3. By End-User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Vocal Biomarker Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technique
      • 5.3.1.2.2. By Indication
      • 5.3.1.2.3. By End-User
  • 5.3.2. India Vocal Biomarker Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technique
      • 5.3.2.2.2. By Indication
      • 5.3.2.2.3. By End-User
  • 5.3.3. Australia Vocal Biomarker Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technique
      • 5.3.3.2.2. By Indication
      • 5.3.3.2.3. By End-User
  • 5.3.4. Japan Vocal Biomarker Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technique
      • 5.3.4.2.2. By Indication
      • 5.3.4.2.3. By End-User
  • 5.3.5. South Korea Vocal Biomarker Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technique
      • 5.3.5.2.2. By Indication
      • 5.3.5.2.3. By End-User

6. Europe Vocal Biomarker Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Indication
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Vocal Biomarker Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End-User
  • 6.3.2. Germany Vocal Biomarker Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End-User
  • 6.3.3. Spain Vocal Biomarker Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End-User
  • 6.3.4. Italy Vocal Biomarker Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technique
      • 6.3.4.2.2. By Indication
      • 6.3.4.2.3. By End-User
  • 6.3.5. United Kingdom Vocal Biomarker Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technique
      • 6.3.5.2.2. By Indication
      • 6.3.5.2.3. By End-User

7. North America Vocal Biomarker Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Indication
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Vocal Biomarker Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End-User
  • 7.3.2. Mexico Vocal Biomarker Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End-User
  • 7.3.3. Canada Vocal Biomarker Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End-User

8. South America Vocal Biomarker Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Indication
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Vocal Biomarker Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End-User
  • 8.3.2. Argentina Vocal Biomarker Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End-User
  • 8.3.3. Colombia Vocal Biomarker Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End-User

9. Middle East and Africa Vocal Biomarker Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Indication
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Vocal Biomarker Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End-User
  • 9.3.2. Saudi Arabia Vocal Biomarker Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End-User
  • 9.3.3. UAE Vocal Biomarker Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End-User
  • 9.3.4. Egypt Vocal Biomarker Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Technique
      • 9.3.4.2.2. By Indication
      • 9.3.4.2.3. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Vocal Biomarker Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. IBM Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Boston Technology Corporation
• 14.3. EVOCAL Health
• 14.4. Audio Profiling
• 14.5. Cogito Corporation
• 14.6. Kintsugi
• 14.7. Sharecare Inc.
• 14.8. Microtest Health
• 14.9. Sonde Health
• 14.10.AudEERING

15. Strategic Recommendations

16. About Us & Disclaimer